Effect of neostigmine on organ injury in murine endotoxemia: Missing facts about the cholinergic antiinflammatory pathway

World Journal of Surgery

Volumn 29, Issue 11, 2005, Pages 1483-1489

  Akinci, Seda B ^a   Ulu, Nadir ^a   Yondem, Omer Z ^a   Firat, Pinar ^a   Guc, M Oguz ^a   Kanbak, Meral ^a   Aypar, Ulku ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; NEOSTIGMINE METHYL SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; ESCHERICHIA COLI; HISTOPATHOLOGY; INFLAMMATION; LIVER INJURY; LIVER WEIGHT; LUNG; LUNG WEIGHT; MALE; MORTALITY; MOUSE; NONHUMAN; ORGAN INJURY; SEPTIC SHOCK; SPLEEN WEIGHT; WEIGHT REDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; ESCHERICHIA COLI INFECTIONS; KIDNEY; LIVER; LUNG; MALE; MICE; MICE, INBRED STRAINS; NEOSTIGMINE; PARASYMPATHOMIMETICS; SHOCK, SEPTIC; SPLEEN;

EID: 28244452587     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-0073-2     Document Type: Article

References (32)

1. Woiciechowsky C, Schoning B, Daberkow N, et al. Brain-IL-1β induces local inflammation but systemic antiinflammatory response through stimulation of both hypothalamic-pituitary-adrenal axis and sympathetic nervous system. Brain Res 1999;816:563-571.
2. Goehler LE, Gaykema RPA, Nguyen KT, et al. Interleukin-1β in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems. J Neurosci 1999;19:2799-2806.
3. Pavlov VA, Wang H, Czura CJ, et al. The cholinergic antiinflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 2003;9:125-134.
4. Tracey KJ, Czura CJ, Ivanova S. Mind over immunity. FASEB J 2001;15:1575-1576.
5. Guarini S, Cainazzo MM, Giuliani D, et al. Adrenocorticotropin reverses hemorrhagic shock in anaesthetized rats through the rapid activation of a vagal antiinflammatory pathway. Cardiovasc Res 2004;63:357-365.
6. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-462.
7. Borovikova LV, Ivanova S, Nardi D, et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Autonom Neurosci 2000;85:141-147.
8. Bernik TR, Friedman SG, Ochani M, et al. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 2002;36:1231-1236.
9. Bernik TR, Friedman SG, Ochani M, et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002;195:781-788.
10. Miranda HF, Sierralta F, Pinardi G. Neostigmine interactions with nonsteroidal antiinflammatory drugs. Br J Pharmacol 2002;135:1591-1597.
11. Grant GJ, Piskoun B, Bansinath M. Intrathecal administration of liposomal neostigmine prolongs analgesia in mice. Acta Anaesthesiol Scand 2002;46:90-94.
12. Roelants F, Lavand'homme PM. Epidural neostigmine combined with sufentanil provides balanced and selective analgesia in early labor. Anesthesiology 2004;101:439-444.
13. Van der spoel JI, Oudemans-van Straaten HM, Stoutenbeek CP, et al. Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure: a prospective, double-blind, placebo-controlled trial. Intensive Care Med 2001;27:822-827.
14. Kiba T, Numata K, Saito S. Neostigmine and polyethylene glycol electrolyte solution for the therapy of acute hepatic encephalopathy with liver cirrhosis and ascites. Hepatogastroenterology 2003;50:823-826.
15. Scremn AM, Scremn OU, Brechner T. Survival under hypoxia: age dependence and effect of cholinergic drugs. Stroke 1980;11:548-552.
16. Introini-Collison IB, Barati CM. Memory-modulatory effects of centrally acting noradrenergic drugs: possible involvement of brain cholinergic mechanisms. Behav Neural Biol 1992;57: 248-255.
17. Rastogi SK, Puri JN, Sinha JN, et al. Involvement of central cholinoceptors in metrazol-induced convulsions. Psychopharmacology 1979;65:215-217.
18. Yilmaz G, Gursoy-Ozdemir Y, Dogan AI, et al. Spleen damage in endotoxemic mice: the involvement of nitric oxide. J Physiol Pharmacol 2001;52:729-744.
19. Vulcano M, Meiss RP, Isturiz MA. Deferoxamine reduces tissue injury and lethality in LPS-treated mice. Int J Immunopharmacol. 2000;22:635-644.
20. Chignard M, Balloy V. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol 2000;279:L1083-L1090.
21. Nakahara T, Kawada T, Sugimachi M, et al. Cholinesterase affects dynamic transduction properties from vagal stimulation to heart rate. Am J Physiol 1998;275:R541-R547.
22. Endou M, Tanito Y, Okumura F. A comparison between chronotropic effects of neostigmine and edrophonium in isolated guinea pig right atrium. J Pharmacol Exp Ther 1997;282:1480-1486.
23. Iskit AB, Sungur A, Gedikoglu G, et al. The effects of bosentan, aminoguanidine, and L-canavanine on mesenteric blood flow, spleen and liver in endotoxemic mice. Eur J Pharmacol 1999;379:73-80.
24. Guc MO. Endoroxin-endothelium interactions in "low-perfusion state" research. J Physiol Pharmacol 1999;50:541-550.
25. Wu Y, Chen Y, Huang H, Chen P. Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice. Acta Pharmacol Sin 2004;25:783-788.
26. Tracey KJ. Lethal weight loss: the focus shifts to signal transduction. Sci STKE 2002;130:PE21.
27. Guarini S, Tagliavini S, Ferrari W, et al. Reversal of haemorrhagic shock in rats by cholinomimetic drugs. Br J Pharmacol 1989;98:218-224.
28. Lin J, Freeman JJ, Kosh JW. Antagonism of acute physostigmine and neostigmine toxicity in mice by hemicholinium-3. Res Commun Chem Pathol Pharmacol 1987;56:137-140.
29. Miceli PC, Jacobson K. Cholinergic pathways modulate experimental dinitrobenzene sulfonic acid colitis in rats. Autonom Neurosci 2003;105:16-24.
30. Beck KD, Brennan FX, Moldow RL, et al. Stress interacts with peripheral cholinesterase inhibitors to cause central nervous system effects. Life Sci 2003;73:41-51.
31. Guarini S, Altavilla D, Cainazzo MM, et al. Efferent vagal fibre stimulation blunts nuclear factor-κB activation and protects against hypovolemic hemorrhagic shock. Circulation 2003;107:1189-1194.
32. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 2003;421:384-388.